title: Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.
abstract: Although changes in nucleotide sequence affecting the composition and the structure of proteins are well known, functional changes resulting from nucleotide substitutions cannot always be inferred from simple analysis of DNA sequence. Because a strong synonymous codon usage bias in the human DRD2 gene, suggesting selection on synonymous positions, was revealed by the relative independence of the G+C content of the third codon positions from the isochoric G+C frequencies, we chose to investigate functional effects of the six known naturally occurring synonymous changes (C132T, G423A, T765C, C939T, C957T, and G1101A) in the human DRD2. We report here that some synonymous mutations in the human DRD2 have functional effects and suggest a novel genetic mechanism. 957T, rather than being 'silent', altered the predicted mRNA folding, led to a decrease in mRNA stability and translation, and dramatically changed dopamine-induced up-regulation of DRD2 expression. 1101A did not show an effect by itself but annulled the above effects of 957T in the compound clone 957T/1101A, demonstrating that combinations of synonymous mutations can have functional consequences drastically different from those of each isolated mutation. C957T was found to be in linkage disequilibrium in a European-American population with the -141C Ins/Del and TaqI 'A' variants, which have been reported to be associated with schizophrenia and alcoholism, respectively. These results call into question some assumptions made about synonymous variation in molecular population genetics and gene-mapping studies of diseases with complex inheritance, and indicate that synonymous variation can have effects of potential pathophysiological and pharmacogenetic importance.
authors.affiliation: Schizophrenia Genetics Research Program, Department of Psychiatry, The University of Chicago, Jules F. Knapp Medical Research Center, Chicago, IL 60637, USA.
authors.forename: Jubao
authors.initials: J
authors.lastname: Duan
authors.forename: Mark S
authors.initials: MS
authors.lastname: Wainwright
authors.forename: Josep M
authors.initials: JM
authors.lastname: Comeron
authors.forename: Naruya
authors.initials: N
authors.lastname: Saitou
authors.forename: Alan R
authors.initials: AR
authors.lastname: Sanders
authors.forename: Joel
authors.initials: J
authors.lastname: Gelernter
authors.forename: Pablo V
authors.initials: PV
authors.lastname: Gejman
mesh_terms: D004298:Dopamine / Q000378:metabolism; D005786:Gene Expression Regulation / Q000235:genetics / Q000502:physiology; D006801:Humans; D009154:Mutation; D009690:Nucleic Acid Conformation; D020641:Polymorphism, Single Nucleotide; D014176:Protein Biosynthesis; D020871:RNA Stability; D012333:RNA, Messenger / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000096:biosynthesis / Q000235:genetics*; D015854:Up-Regulation
chemical_list: D012333:RNA, Messenger; D011954:Receptors, Dopamine; D004298:Dopamine